(4S)-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxylic acid

We are (4S)-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxylic acid CAS:103365-69-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: (4S)-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxylic acid
CAS.NO:   103365-69-1
Synonyms:
4-Pyrimidinecarboxylicacid,hexahydro-1-methyl-2,6-dioxo-,(4S)
1-Methyl-L-4,5-dihydroorotic acid
(S)-3-methyldihydroorotic acid
(S)-1-METHYL-2,6-DIOXOHEXAHYDROPYRIMIDINE-4-CARBOXYLIc acid;
PYR140
1-methyl-(S)-Dio-OH
(4S)-1-Methyl-2,6-Dioxohexahydro-4-Pyrimidinecarboxylic acid

Molecular Formula: C6H8N2O4
Molecular Weight:   172.13900

Physical and Chemical Properties:
Density: 1.449 g/cm3
Boiling point:/
Melting point: 212-214ºC
Flash point: /
Refractive index: 1.526

Specification:
Appearance:  White powder
Purity:≥99.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: 
Intermediates of Taltirelin CAS:103300-74-9.

(4S)-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxylic acid


Related News: Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.136465-81-1 API and raw material are often confused due to the similar usage of the two terms.(4-pyren-1-ylphenyl)boronic acid API and raw material are often confused due to the similar usage of the two terms.trans-1,4-Dibromo-2-butene The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.In terms of business, the industrial business increased by 7.97% year-on-year, while the revenue from the trading business shrank to a certain extent. The growth rate of industrial business was significantly slower than 24% in the first half of the year, showing that the growth rate of industrial business was lower in the third quarter, which was also the main reason for the decline in the company’s operating income in the third quarter. The company’s industrial business is mainly pesticide intermediates, accounting for about 85%. The scale of the pesticide intermediate business is large and the base is high, which is putting pressure on growth.

Related Products
Product Name
{4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]phenyl}methanol View Details
Bis(triphenylphosphine)palladium(II) chloride View Details
6-Iodo-1-hexanol acetate View Details
2-Methyl-2-propanyl 4-(6-{[8-cyclopentyl-5-methyl-7-oxo-6-(1-prop oxyvinyl)-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino}-3-pyridin yl)-1-piperazinecarboxylate manufacturer 8-iodo-1-octanol manufacturer 1-(2-Bromoethoxy)-4-nitrobenzene manufacturer 6-amino-4-chloro-7-ethoxyquinoline-3-carbonitrile manufacturer Dipropylamine manufacturer